Cryoablation for Liver Cancer

Techniques in Vascular and Interventional Radiology

Volumn 10, Issue 1, 2007, Pages 47-57

  Hinshaw, J Louis ^a   Lee Jr , Fred T ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

ablation; cryoablation; hepatocellular carcinoma; liver; metastatic disease

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; HUMAN; KIDNEY CARCINOMA; LAPAROSCOPY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; CRYOSURGERY; HUMANS; LAPAROSCOPY; LIVER NEOPLASMS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 35548970649     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tvir.2007.08.005     Document Type: Article

References (61)

1. Parkin D., Bray F., Ferlay J., et al. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 94 (2001) 153-156
2. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
3. Balsells J., Charco R., Lazaro J.L., et al. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 83 (1996) 758-761
4. Gouillat C., Manganas D., Saguier G., et al. Resection of hepatocellular carcinoma in cirrhotic patients: Longterm results of a prospective study. J Am Coll Surg 189 (1999) 282-290
5. Lencioni R., Cioni D., Crocetti L., et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234 (2005) 961-967
6. Lencioni R., and Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 9 (2005) 301-314 viii
7. Lencioni R., Della Pina C., and Bartolozzi C. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom Imaging 30 (2005) 401-408
8. Yao F.Y., Kinkhabwala M., LaBerge J.M., et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 5 (2005) 795-804
9. Fontana R.J., Hamidullah H., Nghiem H., et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: A safe and effective bridge to liver transplantation. Liver Transpl 8 (2002) 1165-1174
10. Lu D.S., Yu N.C., Raman S.S., et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41 (2005) 1130-1137
11. Choi D., Lim H.K., Rhim H., et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: Long-term results and prognostic factors in a large single-institution series. Eur Radiol 17 (2007) 684-692
12. Lin S.M., Lin C.J., Lin C.C., et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54 (2005) 1151-1156
13. Raut C.P., Izzo F., Marra P., et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 12 (2005) 616-628
14. Lu M.D., Kuang M., Liang L.J., et al. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: A randomized clinical trial]. Zhonghua Yi Xue Za Zhi 86 (2006) 801-805
15. Chen M.S., Li J.Q., Zheng Y., et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243 (2006) 321-328
16. Livraghi T., Goldberg S.N., Lazzaroni S., et al. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection. Radiology 210 (1999) 655-661
17. Liu Z., Ahmed M., Weinstein Y., et al. Characterization of the RF ablation-induced 'oven effect': The importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia 22 (2006) 327-342
18. Gilbert J.C., Onik G.M., Hoddick W.K., et al. Real time ultrasonic monitoring of hepatic cryosurgery. Cryobiology 22 (1985) 319-330
19. Onik G., Cooper C., Goldberg H.I., et al. Ultrasonic characteristics of frozen liver. Cryobiology 21 (1984) 321-328
20. Onik G., Gilbert J., Hoddick W., et al. Sonographic monitoring of hepatic cryosurgery in an experimental animal model. AJR Am J Roentgenol 144 (1985) 1043-1047
21. Lee Jr. F.T., Chosy S.G., Littrup P.J., et al. CT-monitored percutaneous cryoablation in a pig liver model: Pilot study. Radiology 211 (1999) 687-692
22. Silverman S.G., Sun M.R., Tuncali K., et al. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol 183 (2004) 707-712
23. Tacke J., Adam G., Haage P., et al. MR-guided percutaneous cryotherapy of the liver: In vivo evaluation with histologic correlation in an animal model. J Magn Reson Imaging 13 (2001) 50-56
24. Pease G.R., Wong S.T., Roos M.S., et al. MR image-guided control of cryosurgery. J Magn Reson Imaging 5 (1995) 753-760
25. Weber S.M., Lee Jr. F.T., Warner T.F., et al. Hepatic cryoablation: US monitoring of extent of necrosis in normal pig liver. Radiology 207 (1998) 73-77
26. Shock S.A., Laeseke P.F., Sampson L.A., et al. Hepatic hemorrhage caused by percutaneous tumor ablation: Radiofrequency ablation versus cryoablation in a porcine model. Radiology 236 (2005) 125-131
27. Seifert J.K., and Morris D.L. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 23 (1999) 109-113 discussion 113-114
28. Ng K.K., Lam C.M., Poon R.T., et al. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol 11 (2004) 650-657
29. Emmanouilides C., Sfakiotaki G., Androulakis N., et al. Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: A multicenter phase II study. BMC Cancer 7 (2007) 91
30. Aparicio J., Fernandez-Martos C., Vincent J.M., et al. FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancer. Clin Colorectal Cancer 5 (2005) 263-267
31. Pasetto L.M., Jirillo A., Iadicicco G., et al. FOLFOX versus FOLFIRI: A comparison of regimens in the treatment of colorectal cancer metastases. Anticancer Res 25 (2005) 563-576
32. Pawlik T.M., and Choti M.A. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 11 (2007) 1057-1077
33. Wang H., Littrup P.J., Duan Y., et al. Thoracic masses treated with percutaneous cryotherapy: Initial experience with more than 200 procedures. Radiology 235 (2005) 289-298
34. Muller-Schweinitzer E. Arterial smooth muscle function after prolonged exposure to a medium containing dimethyl sulfoxide (Me2SO) and storage at -196 degrees C. Cryobiology 31 (1994) 330-335
35. Clarke D.M., Robilotto A.T., Rhee E., et al. Cryoablation of renal cancer: Variables involved in freezing-induced cell death. Technol Cancer Res Treat 6 (2007) 69-79
36. Woolley M.L., Schulsinger D.A., Durand D.B., et al. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction after renal cryoablation. J Endourol 16 (2002) 519-522
37. Campbell S.C., Krishnamurthi V., Chow G., et al. Renal cryosurgery: Experimental evaluation of treatment parameters. Urology 52 (1998) 29-33 discussion 33-34
38. Gage A.A., and Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 37 (1998) 171-186
39. Cooper I.S., and Hirose T. Application of cryogenic surgery to resection of parenchymal organs. N Engl J Med 274 (1966) 15-18
40. Permpongkosol S., Sulman A., Solomon S.B., et al. Percutaneous computerized tomography guided renal cryoablation using local anesthesia: Pain assessment. J Urol 176 (2006) 915-918
41. Allaf M.E., Varkarakis I.M., Bhayani S.B., et al. Pain control requirements for percutaneous ablation of renal tumors: Cryoablation versus radiofrequency ablation-initial observations. Radiology 237 (2005) 366-370
42. Hinshaw J.L., Laeseke P.F., Winter III T.C., et al. Radiofrequency ablation of peripheral liver tumors: Intraperitoneal 5% dextrose in water decreases postprocedural pain. AJR Am J Roentgenol 186 (2006) S306-S310
43. Laeseke P.F., Sampson L.A., Winter III T.C., et al. Use of dextrose 5% in water instead of saline to protect against inadvertent radiofrequency injuries. AJR Am J Roentgenol 184 (2005) 1026-1027
44. Xu K.C., Niu L.Z., He W.B., et al. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. World J Gastroenterol 9 (2003) 2686-2689
45. Ross W.B., Horton M., Bertolino P., et al. Cryotherapy of liver tumours: A practical guide. HPB Surg 8 (1995) 167-173
46. Crews K.A., Kuhn J.A., McCarty T.M., et al. Cryosurgical ablation of hepatic tumors. Am J Surg 174 (1997) 614-617 discussion 617-618
47. Yeh K.A., Fortunato L., Hoffman J.P., et al. Cryosurgical ablation of hepatic metastases from colorectal carcinomas. Am Surg 63 (1997) 63-68
48. Lehner S.G., Gould J.E., Saad W.E., et al. Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol 185 (2005) 1307-1309
49. Bagia J.S., Perera D.S., and Morris D.L. Renal impairment in hepatic cryotherapy. Cryobiology 36 (1998) 263-267
50. Seifert J.K., Stewart G.J., Hewitt P.M., et al. Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: Association with volume and duration of freezing. World J Surg 23 (1999) 1019-1026
51. Livraghi T., Solbiati L., Meloni M.F., et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology 226 (2003) 441-451
52. de Baere T., Risse O., Kuoch V., et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 181 (2003) 695-700
53. Dodd III G.D., Napier D., Schoolfield J.D., et al. Percutaneous radiofrequency ablation of hepatic tumors: Postablation syndrome. AJR Am J Roentgenol 185 (2005) 51-57
54. Dill-Macky M.J., Asch M., Burns P., et al. Radiofrequency ablation of hepatocellular carcinoma: Predicting success using contrast-enhanced sonography. AJR Am J Roentgenol 186 (2006) S287-S295
55. Minami Y., Kudo M., Kawasaki T., et al. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: Usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 183 (2004) 153-156
56. Meloni M.F., Goldberg S.N., Livraghi T., et al. Hepatocellular carcinoma treated with radiofrequency ablation: Comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 177 (2001) 375-380
57. Cioni D., Lencioni R., Rossi S., et al. Radiofrequency thermal ablation of hepatocellular carcinoma: Using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. AJR Am J Roentgenol 177 (2001) 783-788
58. Solbiati L., Goldberg S.N., Ierace T., et al. Radio-frequency ablation of hepatic metastases: Postprocedural assessment with a US microbubble contrast agent-early experience. Radiology 211 (1999) 643-649
59. Tateishi R., Shiina S., Yoshida H., et al. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 44 (2006) 1518-1527
60. Veit P., Antoch G., Stergar H., et al. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: Initial results. Eur Radiol 16 (2006) 80-87
61. Dromain C., de Baere T., Elias D., et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223 (2002) 255-262